This is a new application for a research training program in Molecular Hematology submitted by a group of investigators who are all on the faculty of Harvard Medical School and work either within HMS or one of its affiliated hospitals or research centers. The grant grew out of a merger between two existing Hematology research training programs centered at the Beth Israel and Brigham and Women's Hospitals and is an attempt to bring together many of the scientists at HMS who work in areas germane to Hematology and are interested in training the postdoctoral fellows to be supported by the Institutional NRSA. The trainees will be selected by a Steering Committee from graduates of clinical training programs at the BWH/MGH and BIH, as well as from the applicants who apply directly-to programs for research training and those nominated by laboratory-preceptors. The overall goal of the program is to train physicians and other interested biomedical)scientists for a career in Hematology Research. Funds are also requested to support the pre-doctoral training of graduate students working in preceptor laboratories and for two Minority summer students. The major areas of Hematology research, including Red Cell Membranes, Hemoglobinopathies, Hematopoiesis, Immunology, Hemostasis/Thrombosis and Vascular Biology, are represented in the grant. Special attention has been paid to a rigorous selection process, adequate mentoring, excellent preceptors and promoting scientific interactions between participating laboratories. In this way the program hopes to take full advantage of the superb resources present at Harvard Medical School and provide optimal training for grant appointees. The merged proposal replaces the existing postdoctoral training positions on the two formerly independent grants.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007623-15
Application #
6139017
Study Section
Research Training Review Committee (RTR)
Project Start
1986-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
15
Fiscal Year
2000
Total Cost
$265,843
Indirect Cost
Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Hideshima, Teru; Qi, Jun; Paranal, Ronald M et al. (2016) Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma. Proc Natl Acad Sci U S A 113:13162-13167
Gerlach, Carmen; Moseman, E Ashley; Loughhead, Scott M et al. (2016) The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. Immunity 45:1270-1284
Zhao, Rui; Deibler, Richard W; Lerou, Paul H et al. (2014) A nontranscriptional role for Oct4 in the regulation of mitotic entry. Proc Natl Acad Sci U S A 111:15768-73
Cahan, Patrick; Li, Hu; Morris, Samantha A et al. (2014) CellNet: network biology applied to stem cell engineering. Cell 158:903-915
Kumar, Roshan M; Cahan, Patrick; Shalek, Alex K et al. (2014) Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature 516:56-61
Morris, Samantha A; Cahan, Patrick; Li, Hu et al. (2014) Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158:889-902
Unternaehrer, Juli J; Zhao, Rui; Kim, Kitai et al. (2014) The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming. Stem Cell Reports 3:691-8
Pantazatos, Dionysios; Gessner, Christopher R; Woods Jr, Virgil L et al. (2014) Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS. Biochem J 461:443-51
Albacker, Colleen E; Storer, Narie Y; Langdon, Erin M et al. (2013) The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish. PLoS One 8:e64969
Cooney, Jeffrey D; Hildick-Smith, Gordon J; Shafizadeh, Ebrahim et al. (2013) Teleost growth factor independence (gfi) genes differentially regulate successive waves of hematopoiesis. Dev Biol 373:431-41

Showing the most recent 10 out of 89 publications